Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v13-EN | Version v6-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2021-09-22 | 2021-08-31 |
| Drug Identification Number | 00828750 | 00828750 |
| Brand name | HEPARIN SOD AND 0.9% SOD CHLORIDE INJ | HEPARIN SOD AND 0.9% SOD CHLORIDE INJ |
| Common or Proper name | Heparin Sodium, USP and Sodium Chloride, USP | Heparin Sodium, USP and Sodium Chloride, USP |
| Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
| Ingredients | HEPARIN SODIUM CHLORIDE | HEPARIN SODIUM CHLORIDE |
| Strength(s) | 2UNIT 9MG | 2UNIT 9MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 24 units/case | 24 units/case |
| ATC code | B01AB | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
| Anticipated start date | 2021-08-31 | 2021-08-31 |
| Actual start date | 2021-08-31 | 2021-08-31 |
| Estimated end date | Unknown | |
| Actual end date | 2021-09-21 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |